Addgene: TEAD Inhibition Overcomes YAP1/TAZ-driven Primary and Acquired Resistance to KRASG12C Inhibitors. Skip to main content
Addgene

TEAD Inhibition Overcomes YAP1/TAZ-driven Primary and Acquired Resistance to KRASG12C Inhibitors.

Edwards AC, Stalnecker CA, Jean Morales A, Taylor KE, Klomp JE, Klomp JA, Waters AM, Sudhakar N, Hallin J, Tang TT, Olson P, Post L, Christensen JG, Cox AD, Der CJ
Cancer Res. 2023 Nov 7. doi: 10.1158/0008-5472.CAN-23-2994. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

Antibodies from Article